Modeling anaplastic medulloblastoma using cerebellar stem cells
|
Duke University / Robert Wechsler-Reya, PhD |
Innovation Grants |
2009 |
North Carolina |
Targeted regulation of acetylation as novel therapy for Ewing sarcoma.
|
Georgetown University / Jeffrey Toretsky |
Innovation Grants |
2009 |
District of Columbia |
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.
|
Huntsman Cancer Institute / Stephen Lessnick |
Innovation Grants |
2009 |
Utah |
Linking mitogenic sonic hedgehog signaling to the oncogene Yap 1 in neural stem/progenitor cells and medulloblastoma.
|
Memorial Sloan-Kettering Cancer Center / Anna Kenney, PhD |
Innovation Grants |
2009 |
New York |
Pharmacogenomics of childhood AML susceptibility and treatment response.
|
Children's Hospital of Philadelphia / Richard Aplenc |
Innovation Grants |
2009 |
Pennsylvania |
BH3 profiling to define therapy resistance classes in neuroblastoma.
|
Children's Hospital of Philadelphia / Michael Hogarty |
Innovation Grants |
2009 |
Pennsylvania |
Adaptation of acute lymphoblastic leukemia (ALL) to the post-transplant allogeneic environment.
|
University of Rochester / Craig Mullen |
Innovation Grants |
2009 |
New York |
Targeting wnt in synovial sarcoma models.
|
Vanderbilt University Medical Center / Josiane Eid |
Innovation Grants |
2009 |
Tennessee |
MLL-based chromosomal translocations in the pathogenesis of childhood leukemia.
|
Children's Mercy / Erin Guest |
Young Investigator Grants |
2009 |
Missouri |
Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors
|
Children's National Medical Center / Suzanne Miles |
Young Investigator Grants |
2009 |
District of Columbia |